Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjms.2022.04.023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Concurrent pseudothrombocytopenia and immune thrombocytopenia.
Am J Med Sci
September 2022
Departments of Internal Medicine and Pathology, Quillen College of Medicine, East Tennessee State University, Johnson City TN USA. Electronic address:
[Correlation factors of ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in cancer patients].
Zhonghua Yi Xue Za Zhi
November 2010
Department of Laboratory Medicine, Cancer Center, SUN Yat-sen University, Guangzhou 510060, China.
Objective: To investigate the correlation factors of ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia (EDTA-PTCP) in cancer patients.
Methods: The potential correlation factors of EDTA-PTCP such as gender, age, case history, tumor types, therapeutic drugs and duration of EDTA-PTCP from cancer patients were analyzed based on the patient records from October 2007 to September 2009 at our cancer center.
Results: A total of 49 EDTA-PTCP cases from a pool of 55 000 cancer patients were collected.
[Laboratory procedures following thrombocytopenia diagnosis].
Vnitr Lek
March 2009
Hemato-onkologické a transfuzní centrum FN Ostrava.
Thrombocytopenia--decrease in the blood platelets count below 100 x 10(9)/L--may represent a significant clinical complication--bleeding. A risk of haemorrhagic complications increases with the severity of thrombocytopenia. Even severe thrombocytopenia, however, may be a sign of a condition with predominant symptoms of thrombosis where bleeding is on the background (thrombotic microangiopathy, for example) or where bleeding occurs concurrently with symptoms of thrombosis (so called thrombohaemorrhagic syndromes).
View Article and Find Full Text PDFSequential measurement of anti-platelet antibodies in a patient who developed EDTA-dependent pseudothrombocytopenia.
Am J Clin Pathol
January 1993
Department of Pathology, University of Maryland Medical System and Hospital, Baltimore 21201.
Ethylenediaminetetraacetic acid (EDTA)-dependent pseudothrombocytopenia is the occurrence of a falsely low platelet count caused by antibodies that agglutinate platelets in the presence of EDTA. If unrecognized, it may result in the erroneous diagnosis of thrombocytopenia and possible inappropriate therapy. It has been noted that this phenomenon tends to appear in hospitalized patients after an initially normal platelet count, but sequential measurements of anti-platelet antibody have not been reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!